Uncategorised - European Medical Journal

High Costs Cause One in Six Adults to Stop Asthma Medication

Financial barriers to asthma medications continue to compromise patient outcomes, increasing the risk of asthma attacks and emergency room visits, according to a recent analysis spanning 2011 to 2022.

Stark Sex Differences in Long COVID Risk

Females are at significantly higher risk of developing long COVID compared to males, according to a recent cohort study involving over 12,000 participants.

Acne Improvements in the First 4 Weeks of Treatment

Fixed-combination topical therapies show improvements in acne within the first 4 weeks of treatment, according to new data compiled from pivotal clinical trials.

Electronic Noses and Breath Profiles for Diagnosing Disease

This infographic highlights the transformative potential of electronic noses (eNoses) in disease diagnosis, monitoring, and treatment…

GSK and Oxford unite to advance cancer vaccine research

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

Health Disparities in MASLD Among Hispanic Adults

Data from 22 studies, encompassing 756,088 subjects, including 62,072 Hispanic adults, revealed striking findings.

TRILUMINATE Imaging Substudy: Sustained Cardiac Remodelling with TriClip

New imaging data show TriClip reduces tricuspid regurgitation and reverses cardiac remodeling, sustaining benefits for one year.

Targeting MRI-Detected Inflammation Improves Axial Spondyloarthritis Management

A groundbreaking analysis of the ESTHER trial reveals that resolution of MRI-detected inflammation in the sacroiliac joints is strongly linked to improved clinical outcomes in patients with axial spondyloarthritis undergoing long-term anti-TNF therapy.

Non-Hormonal Therapies Reduce Menopause Symptoms

Elinzanetant and fezolinetant ease menopause symptoms, with elinzanetant improving sleep and reducing side effects.

Increased Short-Term Risk of Thyroid Cancer After Starting GLP-1RA Therapy

A recent study has revealed an increased risk of thyroid cancer diagnoses within the first year of starting GLP-1RA therapy.